The World Health Organisation (WHO) has announced that new candidate drugs are being tested in the latest phase of global Solidarity clinical trials to find effective treatments against COVID-19.
The therapies — artesunate, imatinib, and infliximab — will be tested on hospitalized COVID-19 patients in 52 countries under the Solidarity PLUS programme.
Speaking during a press conference in Geneva, WHO’s Director-General, Dr. Tedros Ghebreyesus underscored the critical need to find more effective and accessible COVID-19 therapeutics. According to WHO, there have been more than 203 million cases of the disease recorded globally as of Wednesday. The world hit the 200 million mark last week, just six months after cases passed 100 million.
The three drugs were selected by an independent panel for their potential in reducing the risk of death in people hospitalized for COVID-19.
Do join our Telegram Channel so you don’t miss any updates !!